Healio Rheumatology Current Issue
The following articles appeared in the print edition of Healio Rheumatology.
Table of Contents
- All or something: Experts debate LDA vs. remission as a target in rheumatoid arthritis Rob Volansky
-
- The goal of therapy in RA: LDA vs. remission, or perhaps the patient’s well-being Leonard H. Calabrese, DO
- 'Horribly mismanaged': Debate over gout treatment rages as cases surge Jason Laday
- Monoclonal antibody, antiviral therapies struggle to keep pace with COVID-19 variants Rob Volansky
- 'We must do better': Celebrity cases pull autoimmunity epidemic into limelight Nicole Bundy, MD
- Hooked on Rheum with Roy Fleischmann, MD Roy Fleischmann, MD
- Benefits of statins ‘outweigh’ increased diabetes risk in rheumatoid arthritis Jason Laday
- Heart healthy, Mediterranean diets reduce gout risk in women; Western diet increases risk Jason Laday
- Intensive urate target hard to achieve with oral ULT, fails to improve erosion in gout Lisa Holden
-
- Secukinumab improves patient-reported outcomes across all doses in psoriatic arthritis Jason Laday
- mRNA COVID-19 vaccines offer ‘quite encouraging’ long-term protection Rob Volansky
- Much about post-acute COVID syndromes remains ‘poorly defined’ Rob Volansky
- ACR guidelines: ‘Turn the pyramid upside down’ for biologic DMARDs in JIA Erich Martin
- FDA doubles initial Evusheld dosing regimen to enhance prevention of COVID-19 variants Jason Laday